VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 190 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $2,639,000 | -1.5% | 115,000 | -18.2% | 0.18% | +34.1% |
Q2 2018 | $2,679,000 | -21.6% | 140,647 | -30.6% | 0.14% | -4.8% |
Q1 2018 | $3,415,000 | -34.2% | 202,648 | -56.3% | 0.14% | -46.5% |
Q2 2016 | $5,191,000 | -28.7% | 463,900 | -46.7% | 0.27% | -40.0% |
Q1 2016 | $7,282,000 | -13.4% | 871,000 | -3.5% | 0.45% | -47.9% |
Q4 2015 | $8,405,000 | -0.9% | 902,839 | +20.1% | 0.87% | +19.4% |
Q3 2015 | $8,480,000 | -27.8% | 751,760 | -18.8% | 0.73% | +1.7% |
Q2 2015 | $11,753,000 | +116.3% | 926,184 | +58.5% | 0.71% | +112.5% |
Q1 2015 | $5,434,000 | -20.1% | 584,285 | +23.1% | 0.34% | -58.3% |
Q4 2014 | $6,797,000 | -38.2% | 474,673 | -55.2% | 0.80% | +21.1% |
Q3 2014 | $11,003,000 | +255.5% | 1,060,000 | +454.2% | 0.66% | +193.0% |
Q2 2014 | $3,095,000 | +237.1% | 191,250 | +158.4% | 0.23% | +97.4% |
Q4 2013 | $918,000 | -43.2% | 74,000 | -49.8% | 0.12% | -23.8% |
Q3 2013 | $1,615,000 | -34.9% | 147,500 | -52.0% | 0.15% | -40.6% |
Q2 2013 | $2,480,000 | – | 307,000 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |